+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

From
Cancer Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
From
From
Biologics Contract Development Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Contract Development Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
From
Biologics Contract Manufacturing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 182 Pages
  • Global
From
Long-acting ESAs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Long-acting ESAs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Biologics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Tocilizumab Biosimilars Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tocilizumab Biosimilars Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Biopharmaceutical CXO Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biopharmaceutical CXO Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Glycan Analysis Services Market - Global Forecast 2026-2032 - Product Thumbnail Image

Glycan Analysis Services Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 185 Pages
  • Global
From
Ustekinumab Biosimilars Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ustekinumab Biosimilars Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
IL-17 Targeting Biological Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

IL-17 Targeting Biological Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
CD20 Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

CD20 Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Hollow Fiber Filtration Market - Global Forecast 2026-2032 - Product Thumbnail Image

Hollow Fiber Filtration Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
Bioengineered Protein Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioengineered Protein Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Biologics Testing Service Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Testing Service Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more